June 22, 2022, midnight | NVIDIA

The AI Podcast blogs.nvidia.com

It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor.

But professors Artem Cherkasov and Olexandr Isayev were surprised to find that no recent academic papers provided a comprehensive, global research review of how deep learning and GPU-accelerated computing impact drug discovery.

In March, they published a paper in Nature to fill this gap, presenting an up-to-date review of the state of the art for GPU-accelerated …

deep learning discovery drug discovery learning

More from blogs.nvidia.com / The AI Podcast

Data Scientist (m/f/x/d)

@ Symanto Research GmbH & Co. KG | Spain, Germany

Associate Data Engineer

@ Redkite | London, England, United Kingdom

Data Management Associate Consultant

@ SAP | Porto Salvo, PT, 2740-262

NLP & Data Modelling Consultant - SAP LABS

@ SAP | Bengaluru, IN, 560066

Catalog Data Quality Specialist

@ Delivery Hero | Montevideo, Uruguay

Data Analyst for CEO Office with Pathway to Functional Analyst

@ Amar Bank | Jakarta